Protocol for a Research Database for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Sponsor:
CIBMTR
Sponsor Study ID:
T00006
CTO #:
100719
NCT Number:
NCT01166009
Phase:
N/A
Protocol Type:
Other
Age Group:
Both
Disease Sites:
Hodgkin's Lymphoma; Leukemia, other; Lymphoid Leukemia; Multiple Myeloma; Myeloid and Monocytic Leukemia; Non-Hodgkin's Lymphoma; Other Hematopoietic
Study Objectives:
The National Marrow Donor Program® (NMDP) was established in 1986 as the result of a Federal contract that was awarded to create and maintain a registry of volunteer hematopoietic stem cell (HSC) donors. Physicians search the NMDP Registry on behalf of patients in need of an HSC transplant who have no suitably matching related donor. In 1999 the NMDP added a Cord Blood Registry to provide more donor source options for patients in need of an unrelated HSC transplant. Annually, more than 5,000 patients initiate an active donor search through the NMDP and over 3000 of these searches result in transplants. In addition, the Federal contract also recognized that the NMDP could play a critical role in responding to contingency events; primarily radiation and chemical exposures occurring either accidentally or resulting from military or terrorist actions that cause a marrow toxic injury.
eConsent:
Not available
Study Documents:
Open Study Documents
(MUSC NetID required for document access)

For more information about this trial please contact the study team:

Trial opened at the following institutions:

Medical University of South Carolina